BackSummary
Tonix Pharmaceuticals shareholders approved the 2026 Stock Incentive Plan and elected nine directors at the annual meeting on May 7, 2026.
Key takeaways
- Shareholders approved the 2026 Stock Incentive Plan, authorizing equity awards to employees, directors, and consultants.
- Nine directors were elected, including Seth Lederman and Richard Bagger, with broker non-votes on all.
- Ratification of PricewaterhouseCoopers as auditor for fiscal 2026 was approved with 6,910,516 votes for.
- Shareholders authorized the Board to effect reverse stock splits at ratios between 1:2 and 1:250 within two years.
- The Plan was previously adopted by the Board and became effective upon shareholder approval.